Publication | Closed Access
Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
97
Citations
0
References
2002
Year
rFVIIa is a promising adjunctive hemostatic treatment for trauma patients suffering from massive bleeding. Controlled trials are warranted to evaluate the safety and efficacy of this drug.